Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) Short Interest Up 46.2% in March

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKYGet Rating) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 9,500 shares, a growth of 46.2% from the March 15th total of 6,500 shares. Based on an average daily trading volume, of 131,900 shares, the days-to-cover ratio is presently 0.1 days.

OTCMKTS DSNKY traded down $0.17 during trading hours on Friday, reaching $23.27. The company’s stock had a trading volume of 82,218 shares, compared to its average volume of 84,268. The company’s 50-day moving average is $21.90 and its two-hundred day moving average is $23.70. Daiichi Sankyo has a fifty-two week low of $18.05 and a fifty-two week high of $29.09.

About Daiichi Sankyo (Get Rating)

Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for type 2 diabetes mellitus treatment; lacosamide anti-epileptic agent; prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone disorders; teneligliptin for type 2 diabetes mellitus treatment; edoxaban, an anticoagulant; esomeprazole for ulcer treatment; memantine for treating Alzheimer's disease; and laninamivir for anti-influenza treatment.

Read More

Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.